Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

News   Jun 30, 2017 | Original Story from the NIH

 
Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

Diaphragm muscle from SU9516 treated dystrophin deficient mouse showing nuclei (blue), myofibers (outlined in red) and regenerating muscle fibers (green). Credit: Burkin lab at the University of Nevada, Reno School of Medicine

 
 
 

RELATED ARTICLES

Discovery Provides Hope for New Vaccine Against Flesh-eating Bacteria

News

Researchers at Houston Methodist have solved a 100-year-old mystery, providing them a possible key to unlock a pathway for treating diseases caused by flesh-eating bacteria.

READ MORE

Developing a Gene Therapy for Deaf Patients

News

OSU researchers have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it.

READ MORE

Hits for a Novel Drug Target Identified for Depression and Pain

News

Novel small molecules have been identified that might be transformed into a new medical treatment of depression and/or even the potential in the treatment of pain.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE